Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis. - Test2 - elhamkhani - TriplyDB

Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis.

Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis.

http://www.wikidata.org/entity/Q30427045

about

Emerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic?Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness.Relevance of workplace social mixing during influenza pandemics: an experimental modelling study of workplace cultures.An Overview of the 2009 A(H1N1) Pandemic in Europe: Efficiency of the Vaccination and Healthcare Strategies.Lower than expected hepatitis B virus infection prevalence among first generation Koreans in the U.S.: results of HBV screening in the Southern California Inland Empire.HCV infected prisoners: should they be still considered a difficult to treat population?Regulation of influenza virus replication by Wnt/β-catenin signaling.

P2860

Q26783481-2828DB4E-3612-4CB8-9ED7-4E9BAE8E5181 Q28077984-2E054D3C-270F-400A-8565-703C772C80BF Q30363098-8F973A05-C0E1-48D6-B1BC-890B3B7DDCE5 Q30384161-EC93CDE3-C788-429F-B3C4-A58749ADB37A Q30388248-098A38D3-B1F1-4801-8F82-165FE9656DFA Q33678323-E338455A-9FB8-489B-AC9C-D4309E5CE65A Q34941459-427EE05E-B7E4-4720-BB35-F1752ADF086E Q47555181-48A91BEF-EFA8-4904-BA61-68A30D7A02F0

P2860

Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis.

http://www.wikidata.org/entity/Q30427045

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Vaccination strategies for fut ...... d cost effectiveness analysis.

@ast

Vaccination strategies for fut ...... d cost effectiveness analysis.

@en

type

label

Vaccination strategies for fut ...... d cost effectiveness analysis.

@ast

Vaccination strategies for fut ...... d cost effectiveness analysis.

@en

prefLabel

Vaccination strategies for fut ...... d cost effectiveness analysis.

@ast

Vaccination strategies for fut ...... d cost effectiveness analysis.

@en

P1433

Q30427045-C5505CB2-9C69-4159-9DCA-7B85CC647E8C

P1476

Q30427045-7D596D23-64BB-4BDD-8F90-F33E2463BA86

P2093

Q30427045-5D9B1800-9C70-4E90-BCA6-EA4813E5B54F

P2860

Q30427045-0003375F-4BCA-4192-88FD-CC73B4146794

Q30427045-0511210D-95C0-4336-940A-DCA7DBD0691C

Q30427045-08A894ED-C41B-4EB8-9FF6-D7F9FD846512

Q30427045-0A63EEA7-A332-4FB8-88D7-C3880DBF1CE9

Q30427045-0CBBD7C6-33AA-4157-8229-1813A5004C42

Q30427045-0FC9DF53-E4EA-4072-AEBC-B770F61EA33D

Q30427045-11C17186-49BB-4657-AE2C-782344FE1882

Q30427045-13A7F6FA-FC96-4F92-9971-FABAF52E2636

Q30427045-1887FDC6-01FD-4569-8C45-7C9C4501E5E8

Q30427045-1F0C4F33-8999-499B-9DAB-24AE87D345A3

P2888

Q30427045-80E49986-4F0A-40F5-BBDD-2BC8DFC2E379

P304

Q30427045-364520E3-D789-444C-B85D-4030A800FC24

P31

Q30427045-B5BF8717-EF01-4729-86BC-7A1F1E48CA83

P356

Q30427045-7608A0B9-2561-4B91-BFE0-B37506023C37

P478

Q30427045-F4B6BDCD-57C5-44D4-BA05-3B90F041C938

P50

Q30427045-882D2B38-F023-47B2-8B7B-2E792827455C

Q30427045-B23CCC3E-6EC9-4180-BED4-7D0C723FFA84

P577

Q30427045-0471A5C9-4457-4F92-8647-E53C6B3DD56E

P5875

Q30427045-74FAF0F7-0906-4E3A-8877-8A1919ACA9DD

P6179

Q30427045-76CB34C4-43FA-4B54-A78C-98A82A181D71

P698

Q30427045-77489354-EF02-42C2-B1AC-AF30741BEA7C

P921

Q30427045-D0739A40-2CE0-4AA9-94A5-1E71383CF3BD

P932

Q30427045-FA354C44-515A-4D08-80CC-F456E3E8E83C

P356

1471-2334-13-81

P1433

BMC Infectious Diseases

P1476

Vaccination strategies for fut ...... d cost effectiveness analysis.

@en

P2093

Nilimesh Halder

http://www.w3.org/2001/XMLSchema#string

P2860

Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine

Pandemic potential of a strain of influenza A (H1N1): early findings

National Institute for Clinical Excellence and its value judgments

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study

Pandemic versus epidemic influenza mortality: a pattern of changing age distribution

Finding the real case-fatality rate of H5N1 avian influenza

Transmissibility of 1918 pandemic influenza

The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis

Reducing the impact of the next influenza pandemic using household-based public health interventions

Strategies for mitigating an influenza pandemic

P2888

1471-2334-13-81

P304

81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-13-81

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235520236

http://www.w3.org/2001/XMLSchema#string

P6179

1051534939

http://www.w3.org/2001/XMLSchema#string

P698

23398722

http://www.w3.org/2001/XMLSchema#string

P921

P932

3637125

http://www.w3.org/2001/XMLSchema#string